Compare Clorox Co (CLX) vs Citius Pharmaceuticals Inc (CTXR) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Clorox Co vs Citius Pharmaceuticals Inc — how do they compare? Clorox Co trades at $106.55 (market cap $13.09B), while Citius Pharmaceuticals Inc trades at $0.73 (market cap $20.01M). The key difference: Clorox Co is far larger — about 654.2× Citius Pharmaceuticals Inc's market cap, and Clorox Co pays a 4.62% dividend while Citius Pharmaceuticals Inc pays none. Which is the better fit depends on your goals.
| CLX | CTXR | |
|---|---|---|
Market Cap | $13.09B | $20.01M |
Sector | Consumer Staples | Health |
52-Week High | $127.16 | $1.82 |
52-Week Low | $86.12 | $0.48 |
Enterprise Value | $18.47B | $16.23M |
Dividend Yield | 4.62% | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Clorox Co
With a history dating back more than 100 years, Clorox now plays in a variety of categories across the consumer products space, including cleaning supplies, laundry care, trash bags, cat litter, charcoal, food dressings, water-filtration products, and natural personal-care products. Beyond its namesake brand, the firm's portfolio includes Liquid-Plumr, Pine-Sol, S.O.S, Tilex, Kingsford, Fresh Step, Glad, Hidden Valley, KC Masterpiece, Brita, and Burt's Bees. Just shy of 85% of Clorox's sales stem from its home turf.
Read more on CLX →About Citius Pharmaceuticals Inc
Citius Pharmaceuticals is a late-stage biopharmaceutical company focused on critical care products. Its pipeline includes anti-infectives and targeted immune therapies for conditions like cutaneous T-cell lymphoma.
Read more on CTXR →
